Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Jun-24 5:34 PM View:  | Blueprint Medicines Corp (BPMC) | 12-Jun-24 | Grant | 2,242 | -- | -- | 14% 16.01K to 18.25K | |
| 02-Apr-24 4:05 PM View: | Glycomimetics Inc (GLYC) | 29-Mar-24 | Grant | 4,584 | $3.00 | $13,752.00 | 14% 31.74K to 36.33K | |
| 12-Feb-24 4:42 PM View: | Immunogen Inc. (IMGN) | 12-Feb-24 | Disposition | 60,720 | -- | -- | (100%) 60.72K to 0 | |
| 03-Jan-24 5:45 PM View: | Immunogen Inc. (IMGN) | 29-Dec-23 | Grant | 569 | $29.65 | $16,870.80 | < 1% 60.15K to 60.72K | |
| 02-Jan-24 4:05 PM View: | Glycomimetics Inc (GLYC) | 29-Dec-23 | Grant | 5,827 | $2.36 | $13,751.70 | 22% 25.91K to 31.74K | |
| 01-Nov-23 5:59 PM View: | Immunogen Inc. (IMGN) | 30-Oct-23 | Option Exercise | 10,000 | $14.70 | $147,000.00 | 17% 60.15K to 70.15K | |
| 01-Nov-23 5:59 PM View: | Immunogen Inc. (IMGN) | 30-Oct-23 | Option Exercise | 10,000 | $15.08 | $150,800.00 | (14%) 70.15K to 60.15K | |
| 03-Oct-23 4:15 PM View: | Glycomimetics Inc (GLYC) | 30-Sep-23 | Grant | 9,167 | $1.50 | $13,750.50 | 55% 16.75K to 25.91K | (11%) |
| 02-Oct-23 10:00 PM View: | Immunogen Inc. (IMGN) | 29-Sep-23 | Grant | 1,063 | $15.87 | $16,869.80 | 2% 59.09K to 60.15K | |
| 05-Jul-23 5:53 PM View: | Immunogen Inc. (IMGN) | 30-Jun-23 | Grant | 894 | $18.87 | $16,869.80 | 2% 58.19K to 59.09K | |
| 23-Jun-23 7:06 PM View: | Blueprint Medicines Corp (BPMC) | 21-Jun-23 | Grant | 2,600 | -- | -- | 19% 13.41K to 16.01K | |
| 04-Apr-23 4:51 PM View: | Immunogen Inc. (IMGN) | 31-Mar-23 | Grant | 4,394 | $3.84 | $16,873.00 | 8% 53.8K to 58.19K | |
| 30-Jun-22 9:55 PM View: | Blueprint Medicines Corp (BPMC) | 21-Jun-22 | Grant | 2,600 | -- | -- | 24% 10.81K to 13.41K | |
| 07-Mar-22 4:05 PM View: | Blueprint Medicines Corp (BPMC) | 03-Mar-22 | Private Purchase | 5,000 | $59.98 | $299,900.00 | 86% 5.81K to 10.81K | |
| 04-Jun-21 4:21 PM View: | Blueprint Medicines Corp (BPMC) | 02-Jun-21 | Grant | 2,250 | -- | -- | 63% 3.56K to 5.81K | |
| 27-May-21 8:51 PM View: | Glycomimetics Inc (GLYC) | 18-May-21 | Grant | 5,250 | -- | -- | 46% 11.5K to 16.75K | |
| 05-Apr-21 4:30 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Apr-21 | Grant | 10,511 | $1.32 | $13,874.50 | 28% 38.1K to 48.61K | (13%) |
| 06-Jan-21 4:38 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 04-Jan-21 | Grant | 3,452 | $4.02 | $13,877.00 | 10% 34.65K to 38.1K | (72%) |
| 28-Dec-20 4:23 PM View: | Blueprint Medicines Corp (BPMC) | 24-Dec-20 | Option Exercise | 5,455 | $28.15 | $153,558.00 | 153% 3.56K to 9.02K | |
| 28-Dec-20 4:23 PM View: | Blueprint Medicines Corp (BPMC) | 24-Dec-20 | Market Option Sale (Planned) | 5,455 | $125.00 | $681,875.00 | (60%) 9.02K to 3.56K | 23% |
| 22-Dec-20 4:14 PM View: | Blueprint Medicines Corp (BPMC) | 18-Dec-20 | Option Exercise | 5,454 | $28.15 | $153,530.00 | 153% 3.56K to 9.02K | |
| 22-Dec-20 4:14 PM View: | Blueprint Medicines Corp (BPMC) | 18-Dec-20 | Market Option Sale (Planned) | 5,454 | $120.00 | $654,480.00 | (60%) 9.02K to 3.56K | 20% |
| 15-Dec-20 4:08 PM View: | Blueprint Medicines Corp (BPMC) | 11-Dec-20 | Option Exercise | 5,455 | $28.15 | $153,558.00 | 153% 3.56K to 9.02K | |
| 15-Dec-20 4:08 PM View: | Blueprint Medicines Corp (BPMC) | 11-Dec-20 | Market Option Sale (Planned) | 5,455 | $115.00 | $627,325.00 | (60%) 9.02K to 3.56K | 16% |
| 03-Dec-20 4:10 PM View: | Blueprint Medicines Corp (BPMC) | 01-Dec-20 | Option Exercise | 5,454 | $28.15 | $153,530.00 | 153% 3.56K to 9.02K | |
| 03-Dec-20 4:10 PM View: | Blueprint Medicines Corp (BPMC) | 01-Dec-20 | Market Option Sale (Planned) | 5,454 | $110.00 | $599,940.00 | (60%) 9.02K to 3.56K | 12% |
| 21-Oct-20 4:21 PM View: | Blueprint Medicines Corp (BPMC) | 19-Oct-20 | Option Exercise | 5,455 | $19.53 | $106,536.00 | 153% 3.56K to 9.02K | |
| 21-Oct-20 4:21 PM View: | Blueprint Medicines Corp (BPMC) | 19-Oct-20 | Market Option Sale (Planned) | 5,455 | $105.00 | $572,775.00 | (60%) 9.02K to 3.56K | 8% |
| 09-Oct-20 4:04 PM View: | Blueprint Medicines Corp (BPMC) | 07-Oct-20 | Option Exercise | 5,454 | $19.53 | $106,517.00 | 153% 3.56K to 9.02K | |
| 09-Oct-20 4:04 PM View: | Blueprint Medicines Corp (BPMC) | 07-Oct-20 | Market Option Sale (Planned) | 5,454 | $100.00 | $545,400.00 | (60%) 9.02K to 3.56K | 4% |
| 05-Oct-20 4:06 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Oct-20 | Grant | 6,166 | $2.25 | $13,873.50 | 22% 28.48K to 34.65K | (49%) |
| 02-Jul-20 8:58 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Jul-20 | Grant | 7,751 | $1.79 | $13,874.30 | 37% 20.73K to 28.48K | (36%) |
| 26-Jun-20 4:12 PM View: | Blueprint Medicines Corp (BPMC) | 24-Jun-20 | Grant | 2,250 | -- | -- | 171% 1.31K to 3.56K | |
| 23-Jun-20 4:11 PM View: | Blueprint Medicines Corp (BPMC) | 19-Jun-20 | Option Exercise | 1,312 | -- | -- | 100% 0 to 1.31K | |
| 03-Apr-20 5:19 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Apr-20 | Grant | 10,730 | $1.28 | $13,734.40 | 107% 10.0K to 20.73K | (11%) |
| 15-Jan-20 1:27 PM View: | Audentes Therapeutics, Inc. (BOLD) | 15-Jan-20 | Disposition (change in control) | 1,500 | $60.00 | $90,000.00 | (100%) 1.5K to 0 | |
| 20-Dec-18 5:26 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 19-Dec-18 | Market Purchase | 10,000 | $3.19 | $31,897.00 | 100% 0 to 10.0K | (64%) |
| 07-Nov-18 9:54 AM View: | Immunogen Inc. (IMGN) | 06-Nov-18 | Market Purchase | 30,000 | $5.76 | $172,800.00 | 126% 23.8K to 53.8K | 22% |
| 15-Dec-16 11:51 AM View: | Immunogen Inc. (IMGN) | 15-Dec-16 | Market Purchase | 20,000 | $1.80 | $36,000.00 | 526% 3.8K to 23.8K | 292% |
| 07-Mar-16 8:03 AM View: | Glycomimetics Inc (GLYC) | 04-Mar-16 | Market Purchase | 10,397 | $4.77 | $49,630.10 | 945% 1.1K to 11.5K | (44%) |
| 19-Sep-14 5:56 PM View: | Trimeris Inc. (GEVA) | 19-Sep-14 | Option Exercise | 790 | $8.73 | $6,896.70 | 141% 0.56K to 1.35K | |
| 19-Sep-14 5:56 PM View: | Trimeris Inc. (GEVA) | 19-Sep-14 | Market Option Sale (Planned) | 790 | $65.24 | $51,539.60 | (58%) 1.35K to 0.56K | (261%) |
| 18-Sep-14 5:21 PM View: | Trimeris Inc. (GEVA) | 17-Sep-14 | Option Exercise | 4,200 | $8.73 | $36,666.00 | 747% 0.56K to 4.76K | |
| 18-Sep-14 5:21 PM View: | Trimeris Inc. (GEVA) | 17-Sep-14 | Market Option Sale (Planned) | 4,200 | $65.06 | $273,252.00 | (88%) 4.76K to 0.56K | (262%) |
| 18-Sep-14 5:21 PM View: | Trimeris Inc. (GEVA) | 16-Sep-14 | Option Exercise | 9,379 | $8.73 | $81,878.70 | 1669% 0.56K to 9.94K | |
| 18-Sep-14 5:21 PM View: | Trimeris Inc. (GEVA) | 16-Sep-14 | Market Option Sale (Planned) | 9,379 | $65.01 | $609,729.00 | (94%) 9.94K to 0.56K | (263%) |
| 02-Jul-14 5:56 PM View: | Trimeris Inc. (GEVA) | 30-Jun-14 | Grant | 103 | $54.89 | $5,653.67 | 22% 0.46K to 0.56K | |
| 12-Jun-14 5:07 PM View: | Trimeris Inc. (GEVA) | 11-Jun-14 | Option Exercise | 21,597 | $7.66 | $165,513.00 | 4705% 0.46K to 22.06K | |
| 12-Jun-14 5:07 PM View: | Trimeris Inc. (GEVA) | 11-Jun-14 | Market Option Sale (Planned) | 21,597 | $80.00 | $1,727,760.00 | (98%) 22.06K to 0.46K | (195%) |
| 02-Jan-14 7:07 PM View: | Trimeris Inc. (GEVA) | 31-Dec-13 | Grant | 192 | $36.30 | $6,969.60 | 72% 0.27K to 0.46K |